Treatment

VERVE-102 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
This study is testing a new gene-editing treatment called VERVE-102 for people with high cholesterol due to a genetic condition (Familial Hypercholesterolemia) or early heart disease. It aims to see if VERVE-102 is safe and can help lower 'bad' cholesterol.
For: Heterozygous Familial Hypercholesterolemia · Premature Coronary Heart Disease
United States · Australia · Canada